Search research articles
Contact Us
Filters
Showing results (91-100 of 108) with videos related to
Page
of 11
Sort By:
Cold Spring Harbor Molecular Case Studies
|
April 3, 2019
Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with <i>KRAS</i> G12D-mutant lung cancers
Alexander Drilon, Adam J Schoenfeld, Kathryn C Arbour, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 30, 2019
Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices
Natasha Rekhtman, Patrice Desmeules, Anna M Litvak, et al.
JAMA Oncology
|
November 12, 2015
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA
Kasmintan A Schrader, Donavan T Cheng, Vijai Joseph, et al.
JTO Clinical and Research Reports
|
January 5, 2022
Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring <i>KRAS</i> Mutations
Kathryn C Arbour, Eusebio Manchado, Matthew J Bott, et al.
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
H3 dopaminylation and CaMKII modulate diffuse midline glioma response to CDK9 inhibition
Rebecca L Murdaugh, Brittany R Eberl, Rosemary U Richard, et al.
JCO Precision Oncology
|
June 14, 2019
Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung Cancers
Michael Offin, Robin Guo, Stephanie L Wu, et al.
Blood
|
July 3, 2019
CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
Craig S Sauter, Brigitte Senechal, Isabelle Rivière, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2019
Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study
W Victoria Lai, Louisiane Lebas, Tristan A Barnes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 19, 2018
Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers
Alexander Drilon, Jessica J Lin, Thomas Filleron, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 27, 2018
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers
Lara A Dunn, Eric J Sherman, Shrujal S Baxi, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 108) with videos related to
Sort By:
Page
of 11
Cold Spring Harbor Molecular Case Studies
|
April 3, 2019
Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with <i>KRAS</i> G12D-mutant lung cancers
Alexander Drilon, Adam J Schoenfeld, Kathryn C Arbour, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 30, 2019
Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices
Natasha Rekhtman, Patrice Desmeules, Anna M Litvak, et al.
JAMA Oncology
|
November 12, 2015
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA
Kasmintan A Schrader, Donavan T Cheng, Vijai Joseph, et al.
JTO Clinical and Research Reports
|
January 5, 2022
Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring <i>KRAS</i> Mutations
Kathryn C Arbour, Eusebio Manchado, Matthew J Bott, et al.
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
H3 dopaminylation and CaMKII modulate diffuse midline glioma response to CDK9 inhibition
Rebecca L Murdaugh, Brittany R Eberl, Rosemary U Richard, et al.
JCO Precision Oncology
|
June 14, 2019
Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung Cancers
Michael Offin, Robin Guo, Stephanie L Wu, et al.
Blood
|
July 3, 2019
CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
Craig S Sauter, Brigitte Senechal, Isabelle Rivière, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2019
Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study
W Victoria Lai, Louisiane Lebas, Tristan A Barnes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 19, 2018
Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers
Alexander Drilon, Jessica J Lin, Thomas Filleron, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 27, 2018
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers
Lara A Dunn, Eric J Sherman, Shrujal S Baxi, et al.
Page
of 11